Back to Search
LIUZHI ZHANG, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1912656372Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats.
PMID 19638998·J Cereb Blood Flow Metab·2009
7-preclinical
'I felt I have grown up as an adult': caregiving experience of children affected by HIV/AIDS in China.
PMID 19438874·Child Care Health Dev·2009
8-other
Cell growth inhibition by okadaic acid involves gut-enriched Kruppel-like factor mediated enhanced expression of c-Myc.
PMID 17974960·Cancer Res·2007
8-other
The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat.
PMID 17717296·Arterioscler Thromb Vasc Biol·2007
7-preclinical
Parent-adolescent sex communication in China.
PMID 17559012·Eur J Contracept Reprod Health Care·2007
4-observational
Transactivator of transcription-tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo.
PMID 17513614·Mol Cancer Ther·2007
7-preclinical
Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
PMID 16543976·Thromb Haemost·2006
4-observational
Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.
PMID 16959227·Brain Res·2006
7-preclinical
Cell cycle- and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor.
PMID 16543231·J Biol Chem·2006
8-other
Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor.
PMID 15746452·Stroke·2005
7-preclinical
Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
PMID 16316970·Circulation·2005
7-preclinical
Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
PMID 15514182·Stroke·2004
7-preclinical
A proposed injury threshold for mild traumatic brain injury.
PMID 15179853·J Biomech Eng·2004
4-observational
Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
PMID 12756151·Circulation·2003
7-preclinical
Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
PMID 12805500·Stroke·2003
7-preclinical
Computational study of the contribution of the vasculature on the dynamic response of the brain.
PMID 17096223·Stapp Car Crash J·2002
8-other
A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia.
PMID 12100987·J Neurosci Methods·2002
7-preclinical
Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
PMID 11739997·Stroke·2001
7-preclinical
Effect of templated quenched disorder on fluid phase equilibrium.
PMID 11690064·Phys Rev E Stat Nonlin Soft Matter Phys·2001
8-other
Comparison of brain responses between frontal and lateral impacts by finite element modeling.
PMID 11200247·J Neurotrauma·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2799 W GRAND BLVD
DETROIT, MI 48202 - Phone
- (313) 916-9454
Quick Facts
- NPI
- 1912656372
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile